256 related articles for article (PubMed ID: 9458176)
1. Mouse models of human lysosomal diseases.
Suzuki K; Proia RL; Suzuki K
Brain Pathol; 1998 Jan; 8(1):195-215. PubMed ID: 9458176
[TBL] [Abstract][Full Text] [Related]
2. Animal models of lysosomal disease: an overview.
Suzuki K; MÃ¥nsson JE
J Inherit Metab Dis; 1998 Aug; 21(5):540-7. PubMed ID: 9728334
[TBL] [Abstract][Full Text] [Related]
3. Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.
Chen X; Qiu W; Ye J; Han L; Gu X; Zhang H
J Hum Genet; 2016 Apr; 61(4):345-9. PubMed ID: 26740238
[TBL] [Abstract][Full Text] [Related]
4. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
Gehler J
Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
[TBL] [Abstract][Full Text] [Related]
5. Basic findings and current developments in sphingolipidoses.
Pilz H; Heipertz R; Seidel D
Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic abnormalities in diseases of sphingolipid metabolism.
Brady RO
Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
[No Abstract] [Full Text] [Related]
7. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
[TBL] [Abstract][Full Text] [Related]
8. [Lysosomal storage diseases].
Manger B
Z Rheumatol; 2010 Aug; 69(6):527-38. PubMed ID: 20532791
[TBL] [Abstract][Full Text] [Related]
9. Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line, mimicking human Niemann-Pick disease type A. A light and electron microscopic study.
Kuemmel TA; Thiele J; Schroeder R; Stoffel W
Pathol Res Pract; 1997; 193(10):663-71. PubMed ID: 9505258
[TBL] [Abstract][Full Text] [Related]
10. Are animal models useful for understanding the pathophysiology of lysosomal storage disease?
Suzuki K; Ezoe T; Tohyama J; Matsuda J; Vanier MT; Suzuki K
Acta Paediatr Suppl; 2003 Dec; 92(443):54-62; discussion 45. PubMed ID: 14989467
[TBL] [Abstract][Full Text] [Related]
11. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.
Ysselstein D; Shulman JM; Krainc D
Mov Disord; 2019 May; 34(5):614-624. PubMed ID: 30726573
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.
Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR
Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910
[TBL] [Abstract][Full Text] [Related]
13. [Heterogeneity of inborn glycolipidoses and glycoproteinoses and their enzymologic diagnosis].
Tsvetkova IV
Vopr Med Khim; 1982; 28(3):32-41. PubMed ID: 6808764
[No Abstract] [Full Text] [Related]
14. [How does the landscape change in lysosomal storage disease].
Parini R
Pediatr Med Chir; 2007; 29(5):275-8. PubMed ID: 18402399
[No Abstract] [Full Text] [Related]
15. From sheep to mice to cells: tools for the study of the sphingolipidoses.
Zigdon H; Meshcheriakova A; Futerman AH
Biochim Biophys Acta; 2014 Aug; 1841(8):1189-99. PubMed ID: 24607565
[TBL] [Abstract][Full Text] [Related]
16. Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders.
Cho SM; Vardi A; Platt N; Futerman AH
J Neurochem; 2019 Mar; 148(5):625-638. PubMed ID: 29900534
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease.
Crivaro AN; Mucci JM; Bondar CM; Ormazabal ME; Ceci R; Simonaro C; Rozenfeld PA
PLoS One; 2019; 14(5):e0217780. PubMed ID: 31150494
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in sphingolipidosis research].
Tamai Y; Kojima H
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
[No Abstract] [Full Text] [Related]
19. Progress in the understanding and treatment of Fabry disease.
Miller JJ; Kanack AJ; Dahms NM
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129437. PubMed ID: 31526868
[TBL] [Abstract][Full Text] [Related]
20. Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature.
Voorink-Moret M; Goorden SMI; van Kuilenburg ABP; Wijburg FA; Ghauharali-van der Vlugt JMM; Beers-Stet FS; Zoetekouw A; Kulik W; Hollak CEM; Vaz FM
Mol Genet Metab; 2018 Feb; 123(2):76-84. PubMed ID: 29290526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]